Lenalidomide (LEN) pharmacokinetics (PKs) in multiple myeloma (MM) patients (pts) with various renal functions.
2018
8039Background: LEN is a backbone drug used in the treatment of MM. Because over 80% LEN is excreted unchanged in urine, dose modifications for RD are recommended, based on PK evaluation following ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI